Tilray is a global leader in medical cannabis research, cultivation, processing and distribution. We aspire to lead, legitimize and define the future of our industry by building the world’s most trusted cannabis company.

Tilray News

25 Jun

Tilray® Imports Bulk Supply of Medical Cannabis Oil into the United Kingdom

Tilray Inc. (TLRY), a global pioneer in cannabis research, cultivation, production and distribution, today announced it has imported medical cannabis oral solutions in bulk into the United Kingdom from...

25 Jun

Tilray Imports Medical Cannabis to U.K. After Barriers Lifted

(Bloomberg) -- Tilray Inc. has imported its first bulk supply of medical cannabis oil into the U.K., after controversy over the confiscation of one of the Canadian company’s products led to an easing of...

24 Jun

Tilray Gains Big With a 29% Increase Last Week

In the week ending June 21, Tilray (TLRY) was among the biggest gainers in the cannabis sector. Tilray stock gained as much as 29.3% from the closing in the week ending June 14.

24 Jun

Blueberries Announces Appointment of Chief Financial Officer

Blueberries Medical Corp. (CSE: BBM) (BBRRF) (1OA.F) ("Blueberries" or the "Company"), a leading Latin American licensed producer of medicinal cannabis and cannabis-derived products, is pleased to announce...

23 Jun

Nearly Half of All Major Canadian Pot Growers Have Entered the U.S. Hemp Market

CBD-rich hemp could be a high-growth stepping stone into the U.S. for these half-dozen Canadian cannabis stocks.

22 Jun

Better Marijuana Stock: Tilray vs. Green Thumb Industries

Which stock is likely to be the bigger winner between a top Canadian cannabis producer and one of the largest multistate U.S. cannabis companies?

21 Jun

Canopy Growth stock plunges after earnings letdown, Acreage warning

Canopy Growth shares plunged after reporting a larger per-share loss during its fiscal fourth quarter, and warned its merger would hit future profit.

21 Jun

3 Big Stock Charts for Friday: Verizon, General Electric and Ventas

Following through on the gains made earlier this week, the S&P 500 rallied another 0.95% on Thursday, just touching record-highs as a result. Although impressive, the rally is also fragile and may actually...

21 Jun

Why Has Tilray Stock Been Such a Buzzkill?

I certainly don't claim to be any kind of a market guru or super genius, but in my more then 20 years as a hedge fund trader, I picked up a thing or two along the way.Source: Shutterstock One of the...

20 Jun

Existing home sales — What to know in markets Friday

Canopy growth earnings and existing home sales will be on investors' radars Friday.

Load more

About Tilray

Tilray, Inc. engages in the research, cultivation, processing, and distribution of medical cannabis. The company offers its products in Argentina, Australia, Canada, Chile, Croatia, Cyprus, the Czech Republic, Germany, New Zealand, and South Africa. Tilray, Inc. was incorporated in 2018 and is headquartered in Nanaimo, Canada.

A proud pioneer, we are the first GMP-certified medical cannabis producer to supply cannabis flower and extract products to tens of thousands of patients, physicians, pharmacies, hospitals, governments and researchers on five continents.

Tilray's experience is unmatched worldwide. Our team professionals on the ground in 7 countries serves thousands of patients around the globe. Our flagship cultivation facility is among the most advanced in the world.

Tilray is the first GMP-certified medical cannabis producer to supply cannabis flower and extracts. All of our products are produced with meticulous care to ensure the highest quality, consistency and purity for our patients.

We are committed to scientific research that leads to an improved quality of life for patients in a time frame that matters. We partner with leading hospitals and universities to advance the clinical applications of cannabinoids.

Tilray takes tremendous pride in our customer service, patient outreach, and physician interaction. We recognize the importance of tracking potential adverse events as well as therapeutic benefits in order to ensure the safety of our patients.



Governor Howard Dean
Michael Steele
The Honourable Lloyd...
Joschka Fischer
Jaime Gama
The Honourable Alexa...
Rt Hon Sir Donald Mc...
María Lorena Gutiérr...
James O’Brien
Dr. Lorna Marsden
Brendan Kennedy
Chief Executive Officer
Mark Castaneda
Chief Financial Officer
Woody Pastorius
Chief Revenue Officer
Adine Fabiani-Carter
Chief Marketing Officer
Catherine Jacobson
Regulatory & Medical Affairs
Christy Zhou
General Counsel, Tilray Canada
Josh Eades
VP, Chief Science Officer
Scott Krompocker
VP, Operations, Tilray Nanaimo
Philippe Lucas
VP, Patient Research and Access
John Andonoff
VP, Sales & Marketing
Marla Luther
Director of Business Development, Europe
Steven Yoo
Director of Corporate Investments
Sean Carney
Director of Business Development & Government Rela...
Françoise Lévesque
Master Horticulturist
Tom McGaugh
Director of Finance

Participation in events

  • CannMed
  • 300 E Green St, Pasadena, CA 91101, USA


Petrolia Ontario, Canada
13 Jun 2019
Nanaimo British Columbia, Canada
22 Mar 2019
London Ontario, Canada
13 Feb 2019
$ 44.41
Share volume:
642.559 K
Total value:
27.994 M
Market cap:
4.251 B